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Abstract
Background
Large scale efforts to expand access to mental healthcare in low- and middle-income coun-
tries have focused on integrating mental health services into primary care settings using a
task sharing approach delivered by non-specialist health workers. Given the link between
mental disorders and risk of suicide mortality, treating common mental disorders using this
approach may be a key strategy to reducing suicidality.
Methods and findings
The Programme for Improving Mental Health Care (PRIME) evaluated mental health ser-
vices for common mental disorders delivered by non-specialist health workers at ten primary
care facilities in Chitwan, Nepal from 2014 to 2016. In this paper, we present the indirect
impact of treatment on suicidality, as measured by suicidal ideation, among treatment and
comparison cohorts for depression and AUD using multilevel logistic regression. Patients in
the treatment cohort for depression had a greater reduction in ideation relative to those in
the comparison cohort from baseline to three months (OR = 0.16, 95% CI: 0.05–0.59; p =
0.01) and twelve months (OR = 0.31, 95% CI: 0.08–1.12; p = 0.07), with a significant effect
of treatment over time (p = 0.02). Among the AUD cohorts, there were no significant differ-
ences between treatment and comparison cohorts in the change in ideation from baseline to
three months (OR = 0.64, 95% CI: 0.07–6.26; p = 0.70) or twelve months (OR = 0.46, 95%
CI: 0.06–3.27; p = 0.44), and there was no effect of treatment over time (p = 0.72).
Conclusion
The results provide evidence integrated mental health services for depression benefit
patients by accelerating the rate at which suicidal ideation naturally abates over time. Inte-
grated services do not appear to impact ideation among people with AUD, though baseline
levels of ideation were much lower than for those with depression and may have led to floor
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effects. The findings highlight the importance of addressing suicidality as a specific target–
rather than an indirect effect–of treatment in community-based mental healthcare
programs.
Introduction
More than 800,000 people die by suicide each year, with three quarters of suicides occurring in
low- and middle-income countries (LMIC) [1] where scarce resources exist for mental health
care and suicide prevention efforts [2]. The burden of suicide is also increasingly shifting to
Asia given population growth in this region and declining suicide rates in high-income West-
ern countries [3]. The 11 countries in the World Health Organization (WHO) South-East Asia
Region comprises approximately one quarter of the world’s population, yet account for 39%
all suicides [1]. In Nepal, civil unrest, natural disaster, and economic strife have contributed to
rising suicide rates, which is currently a leading cause of mortality among women of reproduc-
tive age [4,5]. Compounding the issue, countries in this region lack adequate health surveil-
lance systems to enumerate suicide rates within their populations [6]. As a result, available
estimates likely underreport the burden of suicide, a finding evidenced by discrepancies
between estimated mortality rates produced by government reports and rigorous research
studies [6].
There has been growing recognition of the need to address suicide as an issue in recent
years. Through the Sustainable Development Goals, the United Nations has set a goal by 2030
to reduce mortality from non-communicable diseases by one third through prevention and
treatment and the promotion of mental health and well-being [7]. Achieving this target is eval-
uated using two indicators: suicide mortality and mortality from non-communicable diseases
[8]. The WHO has also highlighted the importance of addressing the burden of suicide
through the Comprehensive Mental Health Action Plan, which calls for reducing mortality
from suicide by 10% from 2012 to 2020 [9].
Currently, less than one in three people who demonstrate suicidal behaviors (defined as sui-
cidal thoughts, plans, or attempts) receive treatment in middle-income countries, and only
one in six in low-income countries [10]. Some population-level prevention efforts in (LMIC)
have proven effective in reducing mortality, such as pesticide control to reduce access to
means of suicide [11,12]. At the individual level, expanding access to mental health care could
be a key strategy to reducing suicide given the link between mental and substance use disor-
ders and suicidality [13–17]. Between 80% and 98% of people who attempt or complete suicide
have a mental or substance use disorder [14,16], and people with these disorders are at least
ten times more likely to attempt or complete suicide than the general population [13]. In par-
ticular, people with depression, substance use disorders, and psychosis are at greatest risk of
suicidal behavior [13]. Expanding access to mental healthcare can address mental and sub-
stance use disorders underlying increased risk of suicidality. Recent large-scale efforts to
implement and expand access to community-based mental healthcare have focused on inte-
grating mental health services into primary care, with services delivered by non-specialist pri-
mary care workers (PCWs) [18–20]. The WHO established this approach a predominant
strategy to reducing the mental health treatment gap in the Mental Health Gap Action Pro-
gramme (mhGAP), which outlines the implementation and scale up of integrated mental
healthcare using a supervised, stepped care model [21].
The Programme for Improving Mental Health Care (PRIME) implemented mhGAP to
address priority mental health disorders within a district mental health care plan between
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September 2014 and July 2016 in Chitwan, Nepal. The plan included twelve intervention pack-
ages at the community, health facility and organizational level, including community aware-
ness building, stakeholder engagement, and advocacy [22]. At the health facility level, non-
specialist PCWs provided services for four priority mental disorders–alcohol use disorder
(AUD), depression, epilepsy, and psychosis– according to clinical decision-making guidelines
in disorder-specific modules of the mhGAP Intervention Guide (mhGAP-IG) [22–24].
Patients receiving services were screened and referred for serious risk of suicide or self-half
according to the mhGAP-IG, though notably, the mhGAP module on suicide was not included
within PRIME services. A cohort study evaluating the individual-level impact of PRIME inte-
grated mental health services demonstrated small to moderate treatment effects on clinical
symptoms and daily functioning for patients with depression, AUD, and psychosis; treatment
did not appear to have a significant impact on either for patients with epilepsy [25].
While increasing access to mental health care should theoretically reduce suicidality given
the link between suicide and mental disorders, the indirect impact of non-specialist care for
depression and AUD on suicidality has yet to be evaluated at scale. At present, we evaluate the
impact of mental health services delivered by non-specialist PCWs on suicidal ideation among
patients in the PRIME Nepal cohort with depression and AUD, and consider differences in
outcomes across relevant sociodemographic subgroups.
Methods
Setting and participants
PRIME implemented and evaluated district-level mental health care packages in Ethiopia,
India, Nepal, South Africa and Uganda. The cohort study protocol [26], major challenges to
implementation [27], pilot testing [22], and program impact [25] in Nepal are presented else-
where. In brief, mental health services delivered by non-specialist PCWs were implemented at
ten primary health facilities in Chitwan, a predominantly rural district on the central southern
border with India. At the time of study, Chitwan had approximately 580,000 residents and a
literacy rate of 79%, which is greater than the national average of 68% [28]. Previous research
in Chitwan found 11% and 5% of adults screened positive for AUD and depression, respec-
tively [29], while treatment seeking among those who screen positive for either disorder was
less than 2% [30]. Within PRIME, PCWs were trained in the detection, assessment, and treat-
ment provision for priority mental disorders. Health workers provided treatment following
guidelines for clinical decision-making set forth by a module for each disorder in the mhGA-
P-IG [24], which included a combination of pharmacological and psychosocial interventions,
including psychotropic medication, psychoeducation, brief emotional support, and behavioral
and motivational activation. Prior to PRIME, mental health services were only available at the
district hospital and a private medical college.
Participants were eligible to enroll in a cohort if they were above the age of majority (�16
years), resided in Chitwan, were fluent in the local language, and willing and capable of provid-
ing informed consent. People who were already receiving treatment for depression or AUD
during recruitment were not eligible for inclusion.
Study design and recruitment
The primary objective of the study is to evaluate the indirect effect of treatment for depression
and AUD on suicidality (i.e., suicidal thoughts, plans, and attempts) among people who receive
non-specialist services within PRIME Nepal. PRIME field workers approached individuals
attending ten study health facilities in Chitwan for recruitment and informed consent. Field
workers also used proactive community case detection with community informants to identify
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individuals who may be eligible for and benefit from study participation [31]. Eligible patients
who agreed to participate were then screened for depression or AUD by PRIME field workers
prior to their consultation with a primary health care worker. Field workers used the Patient
Health Questionnaire (PHQ-9) [32] to screen for depression and the Alcohol Use Disorder
Identification Test (AUDIT) [33] to screen for AUD. If a participant screened positive, she or
he would complete a psychiatric diagnostic interview by a trained primary health care worker
or medical officer. Those who subsequently received a confirmatory diagnosis for depression
or AUD during diagnostic interview were enrolled in the respective cohort, with priority given
to AUD when both disorders were diagnosed. Participants who screened positive but failed to
receive a confirmatory diagnosis during the diagnostic interview were enrolled into two com-
parison cohorts, one for depression and one for AUD. The comparison cohorts received stan-
dard primary care at the health facilities consisting of assessment, diagnosis, and treatment of
somatic conditions, with no mental health treatment provided.
Participants enrolled in the treatment cohorts received psychotropic medication, psy-
chosocial support, or psychoeducation according to the clinical decision algorithm in the
mhGAP Intervention Guide [24]. Half of participants in each treatment cohort were also
randomly assigned to receive a psychological intervention, the Healthy Activity Program
(HAP) for depression and the Counseling for Alcohol Problems (CAP) for AUD, as part of
a nested randomized control trial [34]. HAP is a behavioral activation therapy delivered
individually over six to eight weekly sessions and includes psychoeducation, activity struc-
turing and monitoring, problem solving, and activating social networks [35]. CAP is a man-
ualized motivational activation delivered individually over four weekly sessions, consisting
of personal appraisal, development cognitive and behavioral skills related to alcohol use,
and management of potential relapse [36]. Health facilities in the study received organiza-
tional support to provide mental health services in the form of an ensured supply of psycho-
tropic medication and mechanisms for monitoring, capacity building, and resource
mobilization.
Measures
The primary outcome, recent suicidal ideation, was assessed through participants responding
to the prompt, “Have you thought of taking your life in the past three months?” via text ques-
tionnaire on electronic tablet. Information was also gathered on past suicide attempts, how-
ever, ideation was selected as the primary outcome since the present study is not sufficiently
powered to detect changes in suicide attempts or completions. To measure depression, partici-
pants reported the frequency of depressive symptoms within the previous two weeks in a
Likert-scale response to nine items using the PHQ-9, each item response ranging from 0 (“not
at all”) to three (“nearly every day”) [32]. A validation study of the PHQ-9 in Nepal indicates
an internal consistency of α = 0.84, with a total score of 10 or above suggesting high risk for
depression at 94% sensitivity and 80% specificity [37]. Participants reported symptoms related
to harmful alcohol use using the ten-item AUDIT, with each item ranging from 0 to 4. The
AUDIT was developed by the WHO and has been used widely in LMIC for the measurement
and detection of AUD [33]. Validation research in Nepal indicates the instrument has an inter-
nal consistency of α = 0.82 [38]. The same study also indicated a cut-off of eight or above has a
sensitivity for detecting alcohol abuse or dependence of 97.2% and 97.5% for females and
males, respectively, and a specificity of 86.7% and 87.8% for females and males, respectively
[38]. All participants completed self-report measures at baseline and three- and twelve-month
follow up. Sociodemographic information was also collected at baseline through self-report
questionnaire.
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Analysis
We used multilevel logistic regression of longitudinal data with participant and primary health
facility random effects to evaluate the difference in odds of suicidal ideation over time and
across treatment and comparison cohorts for depression and AUD, separately. A treatment-
by-time-point interaction term in each model assessed the impact of treatment over time.
Sociodemographic factors significantly associated with ideation in a univariable model were
considered for inclusion in the final regression model. Missing outcome data (15%) were
assumed to be missing at random and were multiply imputed.
Ethics
Ethical approval was obtained from the Nepal Health Research Council; the Faculty of Health
Sciences, University of Cape Town, South Africa; and the WHO, Geneva, Switzerland.
Results
A total of 2,044 people were eligible and consented to take part in the cohort studies. Of these,
137 received a primary diagnosis of depression and enrolled into the treatment cohort, while
72 were enrolled into the depression comparison cohort. Similarly, 175 received a primary
diagnosis of AUD and enrolled in treatment, while 57 were enrolled into the AUD comparison
cohort. Baseline sociodemographic characteristics are presented in Table 1. Participants in the
depression cohorts were predominantly female (treatment: 83.1%, comparison: 87.5%), over
the age of 35 (treatment: 59.1%, comparison: 57.0%), married (treatment: 81.0%, comparison:
88.9%%), and Hindu (treatment: 86.1%, comparison: 80.6%) and had completed less than pri-
mary education (treatment: 55.4%, comparison: 51.4%). Participants in the AUD cohorts were
predominantly male (treatment: 85.1%, comparison: 91.2%), over the age of 35 (treatment
70.8%, comparison: 78.9%), married (treatment: 94.3%, comparison: 87.7%), and Hindu
(treatment: 76.6%, comparison: 84.2%) and had completed primary school or above (treat-
ment: 60.0%, comparison: 54.4%).
Depression cohort
At baseline, 47.5% and 43.1% of participants in the depression treatment and comparison cohorts
reported suicidal ideation, respectively. In the regression model adjusted for relevant sociodemo-
graphic factors, participants in the depression comparison cohort had a 47% reduction in the
odds of suicidal ideation from baseline at three months (odds ratio (OR) = 0.53, 95% confidence
interval (CI): 0.20–1.38; p = 0.19) and a 73% reduction at 12 months (OR = 0.27, 95% CI: 0.10–
0.72; p = 0.01), though the reduction in odds was only significant at 12 months. Adjusted odds of
ideation were marginally greater at baseline for those in the treatment cohort compared to the
comparison cohort (OR = 2.61, 95% CI: 0.98–6.94; p = 0.06), and were significantly lower at 3
months (OR = 0.23, 95% CI: 0.08–0.66; p<0.01) and twelve months (OR = 0.21, 95% CI: 0.07–
0.63; p<0.01) compared to the baseline of the comparison cohort. Odds of ideation for the treat-
ment and comparison cohorts for depression and AUD are depicted in Fig 1.
Those in the treatment cohort had a significantly greater reduction in ideation compared to
the comparison cohort over time, with a 84% greater reduction in odds from baseline to three
months (OR = 0.16, 95% CI: 0.05–0.59; p = 0.01); however, the confidence interval for the dif-
ference between treatment and comparison cohorts from baseline to twelve months crosses
the null (OR = 0.31, 95% CI: 0.08–1.12; p = 0.07). Notably, a Wald test of the interaction term
between treatment and time point indicates a significant effect of treatment over time when
controlling for sociodemographic factors (p = 0.02). A Wald test for follow up also indicates a
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significant secular effect of time (p = 0.03) There is no significant difference between treatment
and comparison cohorts in ideation when holding sociodemographic factors constant and not
allowing the treatment effect to differ over time (OR 2.61, 95% CI: 0.98–6.94; p = 0.06). Results
of adjusted and unadjusted multilevel logistic regression for the depression cohorts are pre-
sented in Table 2.
Age, caste, education level, marriage status, religion, and sex were considered for inclusion
in the regression model for depression after fitting an unadjusted model. Each factor was first
regressed in a univariable model with suicidal ideation; factors significantly associated in the
univariable model were then considered for inclusion in the model of main effects and retained
if found to contribute to model fit. Age and sex were retained in the final adjusted model
through this process. After controlling for other variables, there were no differences when com-
paring odds of ideation among females to males in the depression cohorts (OR = 2.3, 95% CI:
0.75–6.98; p = 0.14), nor was there a significant trend among age categories (p = 0.37).
AUD cohort
At baseline, 21.1% of participants in the treatment cohort and 15.8% of participants in the
comparison cohort reported suicidal ideation. Results of unadjusted and adjusted multilevel
Table 1. Baseline characteristics of the study population by treatment cohort and primary diagnosis.
Depression n (%) Alcohol Use Disorder n (%)
Treatment (n = 137) Comparison (n = 72) p-value� Treatment (n = 175) Comparison n = (57) p-value�
Baseline ideation 65 (47.5%) 31 (43.1%) 0.55 37 (21.1%) 9 (15.8%) 0.38
Male sex 19 (13.9%) 9 (12.5%) 0.78 149 (85.1%) 52 (91.2%) 0.22
Age group (years) 0.21 0.01
�25 19 (13.9%) 16 (22.2%) 4 (2.3%) 2 (3.5%)
26–35 37 (27.0%) 15 (20.8%) 47 (26.9%) 10 (17.5%)
36–50 45 (32.8%) 28 (38.9%) 80 (45.7%) 24 (42.1%)
>50 36 (26.3%) 13 (18.1%) 44 (25.1%) 21 (36.8%)
Education 0.79 0.20
Uneducated or illiterate 38 (27.7%) 17 (23.6%) 37 (21.1%) 9 (15.8%)
Non-formal, less than primary 38 (27.7%) 20 (27.8%) 33 (18.9%) 17 (29.8%)
Primary school and above 61 (44.5%) 35 (48.6%) 105 (60.0%) 31 (54.4%)
Marital status 0.07 0.20
Single 9 (6.6%) 6 (8.3%) 6 (3.4%) 3 (5.3%)
Has a partner 111 (81.0%) 64 (88.9%) 165 (94.3%) 50 (87.7%)
Divorced or widowed 17 (12.4%) 2 (2.8%) 4 (2.3%) 4 (7.0%)
Caste 0.02 0.05
Brahmin or Chhetri 59 (43.1%) 21 (29.2%) 62 (35.4%) 13 (22.8%)
Janajati 38 (27.7%) 15 (20.8%) 44 (25.1%) 18 (31.6%)
Dalit 32 (23.4%) 32 (44.4%) 50 (28.6%) 24 (42.1%)
Others 8 (5.8%) 4 (5.6%) 19 (10.9%) 2 (3.5%)
Religion 0.31 0.30
Muslim 0 (0.0%) 0 (0.0%) 1 (0.6%) 0 (0.0%)
Hindu 118 (86.1%) 58 (80.6%) 134 (76.6%) 48 (84.2%)
Buddhist 13 (9.5%) 7 (9.7%) 31 (17.7%) 9 (15.8%)
Christian 6 (4.4%) 7 (9.7%) 9 (5.1%) 0 (0.0%)
� p-value of χ2 test comparing treatment cohort to comparison cohort within a given disorder
https://doi.org/10.1371/journal.pone.0231158.t001
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logistic regression for the AUD cohorts are presented in Table 3. In a regression model
adjusted for relevant sociodemographic factors, odds of suicidal ideation among patients in
the comparison cohort were not significantly different at three months (OR = 0.45, 95% CI:
0.05–3.69; p = 0.46) or twelve-months (OR = 0.61, 95% CI: 0.11–3.55; p = 0.59) compared to
baseline. Similarly, there were no significant difference in ideation between the comparison
cohort at baseline and the treatment cohort at baseline (OR = 2.20, 95% CI: 0.55–8.88; p =
0.27), three months (OR = 0.64, 95% CI: 0.15–2.80; p = 0.55), or twelve months (OR = 0.62,
95% CI: 0.14–2.69; p = 0.52).
Fig 1. Odds of suicidal ideation for the treatment and comparison cohorts over time. (A) Treatment and
comparison cohorts for depression, adjusted for sex and age category. (B) Treatment and comparison cohorts for
alcohol use disorder (AUD), adjusted for age category.
https://doi.org/10.1371/journal.pone.0231158.g001
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There was no difference in the reduction of ideation between the treatment and comparison
cohorts over time. Changes in ideation were similar between cohorts from baseline to three
months (OR = 0.64, 95% CI: 0.07–6.26; p = 0.70) and twelve months (OR = 0.46, 95% CI:
0.06–3.27; p = 0.44). The Wald test of the interaction between treatment and follow up indi-
cated there is no main effect of treatment over time (p = 0.72), nor was there a secular effect of
time in the comparison cohort (p = 0.71). Holding follow up time point and relevant sociode-
mographic factors constant, there was no difference in ideation between the treatment and
comparison cohorts (OR = 2.14, 95% CI: 0.53–8.62; p = 0.28). Only age was retained in the
adjusted model of main effects when evaluating sociodemographic factors for inclusion in the
process outlined above. After controlling for other variables, suicidal ideation was found to
decrease with increasing age category among AUD cohorts (p = 0.04).
Discussion
We recruited 209 participants into treatment (n = 137) and comparison (n = 72) cohorts for
depression, and 214 participants into treatment (n = 175) and comparison (n = 57) cohorts for
AUD, within a district-wide mental healthcare program at ten health facilities in Chitwan,
Nepal. The program, PRIME, provided mental health services delivered by non-specialist
health workers at primary care facilities; mental health services had previously been available
only at the district hospital and a private medical college. We evaluated the impact of receiving
these services, which implemented WHO mhGAP guidelines for mental health care, on sui-
cidal ideation at three and twelve months.
Table 2. Unadjusted and adjusted logistic regression of suicidal ideation on treatment cohort, timepoint, and demographics for depression.
Unadjusted Adjusted�
Odds ratio for ideation (95% CI) P-value Odds ratio for ideation (95% CI) P-value��
Follow up 0.13�� 0.03��
Comparison cohort
Baseline Ref. Ref.
3 months 0.61 (0.25, 1.45) 0.26 0.53 (0.20, 1.38) 0.19
12 months 0.39 (0.16, 0.96) 0.04 0.27 (0.10, 0.72) 0.01
Treatment cohort
Baseline 1.86 (0.82, 4.22) 0.14 2.61 (0.98, 6.94) 0.06
3 months 0.31 (0.12, 0.80) 0.02 0.23 (0.08, 0.66) <0.01
12 months 0.32 (0.13, 0.80) 0.02 0.21 (0.07, 0.63) <0.01
Cohort
Treatment vs comparison 1.86 (0.82, 4.22) 0.14 2.61 (0.98, 6.94) 0.06
Treatment-by-timepoint interaction 0.10�� 0.02��
Treatment vs. comparison, baseline to 3 months 0.28 (0.09, 0.89) 0.03 0.16 (0.05, 0.59) 0.01
Treatment vs. comparison, baseline to 12 months 0.45 (0.14, 1.41) 0.17 0.31 (0.08, 1.12) 0.07
Sex
Female vs. male – – 2.30 (0.75, 6.98) 0.14
Age group (years) 0.37��
Less than 26 – – Ref.
26 to 35 – – 0.76 (0.25, 2.31) 0.25
36 to 50 – – 0.66 (0.23, 1.88) 0.23
51 or older – – 0.36 (0.11, 1.18) 0.11
�Adjusted for sex and age category
�� p-value for Wald test of interaction terms or multiple factors (e.g., multiple time points)
https://doi.org/10.1371/journal.pone.0231158.t002
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Our findings indicate suicidal ideation declines over the long term among people with
depression, regardless of whether they receive mhGAP services. Notably, those who received
mental health services from non-specialist PCWs had a significantly greater reduction in idea-
tion over time, with this finding driven by a substantial reduction in ideation among the treat-
ment cohort in the short term. Levels of ideation decreased over time for both treatment and
comparison cohort and were similar at long-term follow up. Taken together, these results pro-
vide evidence that treatment for depression by PCWs following mhGAP guidelines benefits
patients by accelerating the rate at which suicidal ideation abates, while those receiving stan-
dard health care experience a more gradual reduction over time. There is substantial value to
reducing suicidality in the short term, not the least of which is a reduced likelihood of death
from suicide, particularly given the high levels of reported ideation among both the treatment
(48%) and comparison (43%) cohorts for depression at baseline.
Participants in the AUD cohorts reported considerably lower levels of ideation than those
in the depression cohorts at baseline, with 20% of those in AUD cohorts reporting ideation
compared to 45% of those in the depression cohorts. This, taken with small cohort sizes, may
have led to floor effects inhibiting our ability to detect significant differences over time and
between cohorts. We found no evidence mhGAP services reduce suicidal ideation among peo-
ple with AUD. There were no differences in suicidal ideation over time, across treatment or
comparison cohorts, or in the effect of treatment over time. The lack of impact on suicidal ide-
ation among people with AUD is troubling given the well-established link between AUD and
risk of suicide [13,17,39]. There was an inverse relationship between likelihood of ideation and
age among the AUD cohorts, which is consistent with research identifying younger age groups
at increased risk of suicide mortality [13].
Table 3. Unadjusted and adjusted logistic regression of suicidal ideation on treatment cohort, timepoint, and demographics for alcohol use disorder.
Unadjusted Adjusted�
Odds ratio for ideation (95% CI) P-value Odds ratio for ideation (95% CI) P-value
Follow up 0.90�� 0.71��
Comparison
Baseline Ref. Ref.
3 months 0.90 (0.21, 3.81) 0.89 0.45 (0.05, 3.69) 0.46
12 months 0.70 (0.16, 3.04) 0.64 0.61 (0.11, 3.55) 0.59
Treatment
Baseline 2.08 (0.65, 6.63) 0.22 2.20 (0.55, 8.88) 0.27
3 months 0.97 (0.29, 3.25) 0.96 0.64 (0.15, 2.80) 0.55
12 months 0.97 (0.29, 3.31) 0.96 0.62 (0.14, 2.69) 0.52
Cohort
Treatment vs. comparison 2.08 (0.65, 6.63) 0.43 2.14 (0.53, 8.62) 0.28
Treatment-by-time point interaction 0.74�� 0.72��
Treatment vs. comparison, baseline to 3 months 0.52 (0.10, 2.77) 0.44 0.64 (0.07, 6.26) 0.70
Treatment vs. comparison, baseline to 12 months 0.67 (0.13, 3.38) 0.63 0.46 (0.06, 3.27) 0.44
Age group (years) 0.04��
Less than 26 – – Ref.
26 to 35 – – 0.64 (0.05, 8.37) 0.74
36 to 50 – – 0.20 (0.02, 2.54) 0.21
51 or older – – 0.11 (0.01, 1.65) 0.11
�Adjusted for age category
�� p-value for Wald test of interaction terms or multiple factors (e.g., multiple time points, age categories)
https://doi.org/10.1371/journal.pone.0231158.t003
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These findings demonstrate the indirect effects of reducing clinical symptoms of depression
on suicidality, rather than directly addressing suicidality as a therapeutic target. Reducing clin-
ical symptoms and improving functionality are positive ways to affect suicidality through bet-
ter overall wellbeing, and we provide evidence here to support this among people with
depression. However, our evidence highlights the need for non-specialist health workers to be
trained and comfortable in addressing all of a patient’s needs, including if she or he is express-
ing signs of suicidality. According to the depression and AUD modules of the mhGAP-IG
guidelines, patients who report suicidality and pose a threat to themselves or others are identi-
fied and referred [24]. However, there are no directions for how to treat suicidality within the
primary care context beyond identification within these modules. Adding the mhGAP-IG
module on suicide to the roll out of the mhGAP may be an effective way to provide more direct
mental health care for people at risk of suicide. Having health workers trained in this module
might also augment the potential for health workers to improve suicidality among people with
AUD, as well as increase the likelihood of sustained effect on reduced suicidality among people
with depression, as both of these effects could not be established in the current approach.
Moreover, such additional training will certainly be relevant for people who report more seri-
ous suicidal behavior, such as suicide plans or attempts.
Currently there is an insufficient evidence base to determine whether large-scale programs
providing mental health services by non-specialists in primary care are an effective approach
to reducing suicide in LMIC. Nepal is one of five countries within PRIME implementing a dis-
trict-wide mental health care plan; research should be extended to consider the impact of these
services on suicidality, particularly suicide attempts and mortality, across all country sites.
Cross-cultural differences may affect the generalizability of these findings outside of Asia.
Some research suggests suicide in Asia is influenced more heavily by socioeconomic circum-
stances than mental health issues [11], which may indicate the burden of suicide would be less
affected by expanded mental health care in Nepal than in other settings. Considered another
way, suicide prevention approaches in this context may need to be integrated with economic
or livelihood interventions to achieve substantial reductions in mortality by suicide. Future
suicide prevention programming should also address the role of gender-based violence, dis-
crimination, and other underlying factors contributing to suicidality in South Asia [40–42].
Evidence from high-income countries on the effectiveness of large-scale mental health pro-
grams in reducing suicide mortality is also mixed. A recent study of a multi-level suicide pre-
vention program in Europe, which included capacity building, mass media campaigns, and
interventions for high-risk groups, found no impact on suicidal acts in three of four country
sites [43,44]. This evidence is in line with a 2016 systematic review by Zalsman and colleagues,
which found strongest evidence for restricting access to lethal means through policy interven-
tions, followed by moderate evidence for pharmacological interventions specifically for depres-
sion, and weak evidence for family- and community-based intervention [12].
This study is not without limitations; the first of which is the limited comparability between
the treatment and comparison cohorts. Participants who screened positive but did not subse-
quently receive a confirmatory diagnosis during diagnostic interview were enrolled into com-
parison conditions, which differs from a traditional control condition and limits the validity of
cross-cohort comparisons. However, any bias would likely be towards the null given the com-
parison cohorts comprise less clinically severe samples to which the treatment cohorts are
compared. Bias is nonetheless unlikely given the similar levels of reported ideation between
cohorts at baseline. Secondly, we evaluate suicidal ideation rather than attempts or comple-
tions given the rare occurrence of either. While the three are all interrelated components of
suicidality, we are not able to provide evidence for the impact of these services on rates of sui-
cide attempts or mortality, only ideation. Lastly, as is typical with cohort studies, the small
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sample size in the comparison cohorts limits our ability to detect significant differences, partic-
ularly in subgroup analyses.
Conclusion
Mental health services for depression provided by non-specialist primary care workers indi-
rectly reduce suicidal ideation among this patient population in the short term. Our findings
suggests the indirect benefits of treatment for depression may be in accelerating the rate at
which suicidal ideation naturally abates over time. Further research is needed to understand
the mechanisms through which treatment for depression reduces suicidality in this context,
such as exploring the moderating effects of treatment response and adherence. Non-specialist
delivered services do not appear to impact ideation among people with AUD, though findings
are limited by small sample sizes, low levels of baseline ideation, and an imperfect comparison
cohort. Nonetheless, these findings highlight the importance of addressing suicidality as a spe-
cific target–rather than an indirect effect–of treatment in community-based mental health care
programs and support the argument for including the mhGAP module on suicidality along-
side programs addressing priority mental disorders within primary care.
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